INSIGHTS ON CLINICAL TRIAL DESIGN

• Harnessing Predictive Modeling To Overcome Trial Enrollment Challenges

  By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures clinical trials meet their enrollment goals more efficiently.

• Digital Transformation As A Foundation For Modern Chronic Disease Trials

  Site-centric chronic trials cause patient burden. Learn how wearables and a decentralized model can shift research to continuous data capture, removing travel barriers to improve retention and disease tracking.

• Virtual eConsent For Decentralized Trials

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

• BCVA, OCT, And IOP Testing In Clinical Trials

  2/9/2026

  Are minor inconsistencies in room setup and technician technique quietly compromising your study data? Learn how closing small operational gaps can prevent major downstream risks.

• Mid-Study Randomization: Ensuring Data Integrity In Oncology Trials

  7/5/2026

  Miscommunication between supply chain vendors risks costly delays. Discover how unifying physical and digital operations catches issues before they disrupt a trial.

• The Healing Power Of Support Groups

  10/20/2025

  Support groups offer emotional strength and connection for patients and caregivers, helping them navigate medical challenges, treatment journeys, and the complexities of chronic conditions.

• Bring Your Own Device (BYOD) Clinical Trials

  4/8/2025

  Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.

• Understanding The FDA's Push For More Representation In Clinical Trials

  1/28/2025

  Take action to improve diversity in clinical trials by addressing underrepresentation and ensuring equitable access to medical interventions, as emphasized by the FDA’s new 2025 guidance.